Publikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (10)

2022

  1. Specialized Proresolving Mediators Protect Against Experimental Autoimmune Myocarditis by Modulating Ca2+ Handling and NRF2 Activation

    JACC: Basic to Translational Science, Vol. 7, Núm. 6, pp. 544-560

2018

  1. Selective effects of Δ9-tetrahydrocannabinol on medium spiny neurons in the striatum

    PLoS ONE, Vol. 13, Núm. 7

2017

  1. Insulin regulates astrocytic glucose handling through cooperation with IGF-I

    Diabetes, Vol. 66, Núm. 1, pp. 64-74

2016

  1. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

    Neuroscience, Vol. 339, pp. 191-209

2014

  1. A longitudinal FDG-PET study of transgenic mice overexpressing GSK- 3β in the brain

    Current Alzheimer Research, Vol. 11, Núm. 2, pp. 175-181

  2. DREAM controls the on/off switch of specific activity-dependent transcription pathways

    Molecular and Cellular Biology, Vol. 34, Núm. 5, pp. 877-887

  3. Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging

    Journal of Alzheimer's Disease, Vol. 40, Núm. S1

2013

  1. Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of parkinson's disease

    CNS and Neurological Disorders - Drug Targets, Vol. 12, Núm. 5, pp. 665-679

2012

  1. Prolonged oral cannabinoid administration prevents neuroinflammation, lowers β-amyloid levels and improves cognitive performance in Tg APP 2576 mice

    Journal of Neuroinflammation, Vol. 9

2011

  1. Statistical parametric maps of 18F-FDG PET and 3-D autoradiography in the rat brain: A cross-validation study

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, Núm. 12, pp. 2228-2237